Trial intelligence / Profile preview

Micronutrients and Antenatal Steroids in Premature Neonates

NCT03366584Phase 4Unknown

Sponsor
Universitas Indonesia
Start
Jan 2017
Primary completion
Dec 2018
Countries
1
01

Overview

Phase 4, randomised, open-label trial (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Hyaline Membrane Disease at 1.5 years. Status: unknown.

Beyond the preview

Go deeper on NCT03366584.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03366584.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call